Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma

Fig. 4Fig. 4

OS for different IPI risk stratification of PTCL patients. A OS of patients with different LMR levels in group of IPI score 0–2; B OS of patients with different PMR levels in group of IPI score 0–2; C OS of patients with different LMR levels in group of IPI score 3–5; D OS of patients with different PMR levels in group of IPI score 3–5

Back to article page